Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy

Background and Purpose— Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. Methods— All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case–control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ⩽7 mL/min·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). Results— One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63–0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (&kgr;=0.6). Conclusions— Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.

[1]  Neil Pearce,et al.  Analysis of matched case-control studies , 2016, British Medical Journal.

[2]  Richard Frayne,et al.  Time-Dependent Computed Tomographic Perfusion Thresholds for Patients With Acute Ischemic Stroke , 2015, Stroke.

[3]  R. Bammer,et al.  Reperfusion of Very Low Cerebral Blood Volume Lesion Predicts Parenchymal Hematoma After Endovascular Therapy , 2015, Stroke.

[4]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[5]  Mikito Hayakawa Reperfusion-Related Intracerebral Hemorrhage. , 2015, Frontiers of neurology and neuroscience.

[6]  J. Krakauer,et al.  Pretreatment Blood–Brain Barrier Damage and Post-Treatment Intracranial Hemorrhage in Patients Receiving Intravenous Tissue-Type Plasminogen Activator , 2014, Stroke.

[7]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  G. Donnan,et al.  Prediction of Poststroke Hemorrhagic Transformation Using Computed Tomography Perfusion , 2013, Stroke.

[9]  E. Sander Connolly,et al.  Hemorrhagic Transformation: A Review of the Rate of Hemorrhage in the Major Clinical Trials of Acute Ischemic Stroke , 2013, Front. Neurol..

[10]  Leonid Churilov,et al.  Advanced imaging improves prediction of hemorrhage after stroke thrombolysis , 2013, Annals of neurology.

[11]  Ting-Yim Lee,et al.  The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors. , 2013, Academic radiology.

[12]  Eric E. Smith,et al.  Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator , 2012, Stroke.

[13]  M. Kaste,et al.  Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score , 2012, Annals of neurology.

[14]  P. Barber,et al.  Regional Very Low Cerebral Blood Volume Predicts Hemorrhagic Transformation Better Than Diffusion-Weighted Imaging Volume and Thresholded Apparent Diffusion Coefficient in Acute Ischemic Stroke , 2010, Stroke.

[15]  Scott E Kasner,et al.  Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials , 2009, Stroke.

[16]  Ting-Yim Lee,et al.  Hemorrhagic Transformation of Ischemic Stroke: Prediction with CT , 2009 .

[17]  Gary A. Ford,et al.  Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.

[18]  G Schlaug,et al.  The HAT Score , 2008, Neurology.

[19]  R. Bammer,et al.  Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke , 2007, Stroke.

[20]  Ernst Klotz,et al.  Ischemic brain tissue water content: CT monitoring during middle cerebral artery occlusion and reperfusion in rats. , 2007, Radiology.

[21]  A. Demchuk,et al.  Can we identify a CT‐based tissue window for thrombolysis without CTP? , 2006, Annals of neurology.

[22]  D. Cheresh,et al.  Pathophysiological consequences of VEGF-induced vascular permeability , 2005, Nature.

[23]  A. Malik,et al.  Functional role of TRPC channels in the regulation of endothelial permeability , 2005, Pflügers Archiv.

[24]  Michael Forsting,et al.  Brain Tissue Water Uptake after Middle Cerebral Artery Occlusion Assessed with CT , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[25]  T-Y Lee,et al.  CT imaging of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[26]  T. Davis,et al.  Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke , 2002, Stroke.

[27]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[28]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[29]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .